COSCIENS Biopharma (CSCI) 6-K Report of Voting Results

Exhibit 99.1

AETERNA ZENTARIS INC.

Report of Voting Results

Submitted Pursuant to

Section 11.3 of National Instrument 51-102 – Continuous Disclosure Obligations

June 21, 2022

In accordance with Section 11.3 of National Instrument 51-102 – Continuous Disclosure Obligations, this report describes the matters voted upon and the outcome of the votes at the annual general meeting of shareholders of Aeterna Zentaris Inc. (the “Company”) held on June 21, 2022 via live audio webcast. Each of the matters is described in greater detail in the Company’s management information circular dated May 16, 2022 (the “Circular”).

(a) The five nominees set forth in the Circular were elected as directors of the Company to hold office until the close of the next annual meeting of the Company’s shareholders or until their successors are duly elected or appointed. The following are the voting results on this matter:

	FOR		% FOR			WITHHELD		%WITHHELD
Peter Edwards		10,264,600		75.75	%		3,285,758		24.25	%
Carolyn Egbert		9,712,946		71.68	%		3,837,412		28.32	%
Gilles Gagnon		9,719,864		71.73	%		3,830,494		28.27	%
Klaus Paulini		10,178,648		75.12	%		3,371,711		24.88	%
Dennis Turpin		10,375,735		76.57	%		3,174,623		23.43	%

(b) Ernst & Young LLP was appointed as the Company’s auditors and the directors were authorized to fix the remuneration to be paid to the auditors. The following are the voting results on this matter:

	FOR		% FOR			WITHHELD		% WITHHELD
Appointment of Auditors		28,148,915		85.49	%		4,777,318		14.51	%

(c) The Company’s Amended and Restated Shareholder Rights plan was reconfirmed and approved.

	FOR		% FOR			WITHHELD		% WITHHELD
Shareholder Rights Plan		7,464,681		55.09	%		6,085,677		44.91	%

Dated this 21^st day of June, 2022.

AETERNA ZENTARIS INC.
By:	(signed) Giuliano La Fratta
Name:	Giuliano La Fratta
Title:	Chief Financial Officer